Search research articles
Contact Us
Filters
Showing results (161-170 of 274) with videos related to
Page
of 28
Sort By:
Journal of Hematology & Oncology
|
August 9, 2020
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma
Samrat Roy Choudhury, Cody Ashby, Ruslana Tytarenko, et al.
Haematologica
|
January 11, 2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease
Mateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
Clinical Hematology International
|
September 30, 2024
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Tanvi H Patel, Ramya Bachu, Trilok Shrivastava, et al.
Blood Cancer Journal
|
August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
Jeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
Blood
|
May 22, 2008
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities
Bart Barlogie, Mauricio Pineda-Roman, Frits van Rhee, et al.
Blood Advances
|
November 22, 2021
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma
Meera Mohan, Samantha Kendrick, Aniko Szabo, et al.
Blood Advances
|
January 9, 2025
Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
Samer Al Hadidi, Obada Ababneh, Carolina Schinke, et al.
The Journal of Clinical Investigation
|
October 26, 2023
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions
Fumou Sun, Yan Cheng, Jin-Ran Chen, et al.
Haematologica
|
May 30, 2015
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)
Rashid Khan, Madhav Dhodapkar, Adam Rosenthal, et al.
Blood
|
September 27, 2007
Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989
Bart Barlogie, Guido Tricot, Jeff Haessler, et al.
Page
of 28
Search research articles
Search
Showing results (161-170 of 274) with videos related to
Sort By:
Page
of 28
Journal of Hematology & Oncology
|
August 9, 2020
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma
Samrat Roy Choudhury, Cody Ashby, Ruslana Tytarenko, et al.
Haematologica
|
January 11, 2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease
Mateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
Clinical Hematology International
|
September 30, 2024
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Tanvi H Patel, Ramya Bachu, Trilok Shrivastava, et al.
Blood Cancer Journal
|
August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
Jeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
Blood
|
May 22, 2008
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities
Bart Barlogie, Mauricio Pineda-Roman, Frits van Rhee, et al.
Blood Advances
|
November 22, 2021
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma
Meera Mohan, Samantha Kendrick, Aniko Szabo, et al.
Blood Advances
|
January 9, 2025
Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
Samer Al Hadidi, Obada Ababneh, Carolina Schinke, et al.
The Journal of Clinical Investigation
|
October 26, 2023
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions
Fumou Sun, Yan Cheng, Jin-Ran Chen, et al.
Haematologica
|
May 30, 2015
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)
Rashid Khan, Madhav Dhodapkar, Adam Rosenthal, et al.
Blood
|
September 27, 2007
Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989
Bart Barlogie, Guido Tricot, Jeff Haessler, et al.
Page
of 28